Gadopentetate Dimeglumine
Generic Name: gadopentetate dimeglumine
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: GADOPENTETATE DIMEGLUMINE (469.01MG/ML). Application: NDA021037.
Overview
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: GADOPENTETATE DIMEGLUMINE (469.01MG/ML). Application: NDA021037.
Dosage
Available as injectable for injection use.
Related Medications
Gemtuzumab Ozogamicin
gemtuzumab ozogamicin
CD33-directed Immunoconjugate [EPC]
11 DESCRIPTION Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) composed of the CD33-directed monoclonal antibody (hP67.6; recombinant humanized immunoglobulin [Ig] G4, kappa antibody produced by mammalian cell culture in NS0 cells) that is covalently linked to the cytotoxic agent N-acetyl gamma calicheamicin. Gemtuzumab ozogamicin consists of conjugated and unconjugated gemtuzumab.
4% Lidocaine
4% lidocaine
Amide Local Anesthetic [EPC]
Topical Anesthetic
Adeps Bovis,cera Alba,mel
adeps bovis,cera alba,mel
Moisturizing
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.